The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target

The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target

The COVID-19 pandemic caused by the SARS-CoV-2 virus is still a global health concern. Several spike (S) protein-based vaccines have been developed that efficiently protect the human population against severe forms of COVID-19. However, some SARS-CoV-2 variants of concern (VOCs) have emerged that ev...

Detaylı Bibliyografya
Yazar:	Teresa Santos-Mendoza
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	MDPI AG 2023-04-01
Seri Bilgileri:	Viruses
Konular:	coronavirus E protein PDZ-dependent interactions antivirals
Online Erişim:	https://www.mdpi.com/1999-4915/15/4/1000

Benzer Materyaller

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
Yazar:: Luis H. Gutiérrez-González, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence
Yazar:: Jose M. Honrubia, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins
Yazar:: Yanlei Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery
Yazar:: Austin Royster, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
Yazar:: Kuldeep Singh Patel, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

SARS-CoV-2-human protein-protein interaction network
Yazar:: Babak Khorsand, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
Yazar:: Sijia He, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

SARS-CoV-2 envelope protein topology in eukaryotic membranes
Yazar:: Gerard Duart, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Interference of HTLV-1 Tax Protein with Cell Polarity Regulators: Defining the Subcellular Localization of the Tax-DLG1 Interaction
Yazar:: Federico Marziali, ve diğerleri
Baskı/Yayın Bilgisi: (2017-11-01)

PDZ2-conjugated-PLGA nanoparticles are tiny heroes in the battle against SARS-CoV-2
Yazar:: Noah Giacon, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
Yazar:: Paolo Calligari, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Deciphering the Molecular Interaction Between the Adhesion G Protein-Coupled Receptor ADGRV1 and its PDZ-Containing Regulator PDZD7
Yazar:: Baptiste Colcombet-Cazenave, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro
Yazar:: Bruno A. Rodriguez-Rodriguez, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Proteome‐wide analysis of phospho‐regulated PDZ domain interactions
Yazar:: Gustav N Sundell, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Identifying Structural Features of Nucleotide Analogues to Overcome SARS-CoV-2 Exonuclease Activity
Yazar:: Xuanting Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Yazar:: Jessica Wagoner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis
Yazar:: Carlos Castaño-Rodriguez, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators
Yazar:: Jose M. Honrubia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture
Yazar:: Allison Bakovic, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
Yazar:: João Trigueiro-Louro, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods
Yazar:: Nupur S. Munjal, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

In-silico comparison of post-translational modifications of SARS-CoV and SARS-CoV-2 structural proteins
Yazar:: Naghmeh Soltani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Domain Analysis and Motif Matcher (DAMM): A Program to Predict Selectivity Determinants in <i>Monosiga brevicollis</i> PDZ Domains Using Human PDZ Data
Yazar:: Haley A. Wofford, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Yazar:: Mei-Yue Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Ankrd1-mediated signaling is supported by its interaction with zonula occludens-1
Yazar:: Nestorović Aleksandra, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

The Interaction of the Transmembrane Domain of SARS-CoV-2 E-Protein with Glycyrrhizic Acid in Lipid Bilayer
Yazar:: Polina A. Kononova, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

The adaptor protein PICK1 targets the sorting receptor SorLA
Yazar:: Lars Binkle, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain
Yazar:: Bin Gao, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Emerging mutations in envelope protein of SARS-CoV-2 and their effect on thermodynamic properties
Yazar:: Kejie Mou, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases
Yazar:: Wiljan Hendriks, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Aspects of the physiochemical properties of SARS-CoV-2 to prevent S-protein receptor binding using Arabic gum
Yazar:: Ghobashy Mohamed Mohamady, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein
Yazar:: Yanping Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
Yazar:: Soo Jin Oh, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients
Yazar:: Daniele Lombardo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Exploring essential oils as prospective therapy against the ravaging Coronavirus (SARS-CoV-2)
Yazar:: Emmanuel Onah Ojah
Baskı/Yayın Bilgisi: (2020-06-01)

The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity
Yazar:: Dewald Schoeman, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations
Yazar:: Rui Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Interactions of the protein tyrosine phosphatase PTPN3 with viral and cellular partners through its PDZ domain: insights into structural determinants and phosphatase activity
Yazar:: Mariano Genera, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
Yazar:: Damir Bojadzic, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
Yazar:: Lizdany Flórez-Álvarez, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)